Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Withdrawn Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs